Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Dec;102(6):1723-8.
doi: 10.1016/j.fertnstert.2014.08.014. Epub 2014 Sep 23.

BRCA1 germline mutations may be associated with reduced ovarian reserve

Erica T Wang  1 , Margareta D Pisarska  2 , Catherine Bresee  3 , Yii-Der Ida Chen  4 , Jenny Lester  5 , Yalda Afshar  6 , Carolyn Alexander  2 , Beth Y Karlan  5
Affiliations

BRCA1 germline mutations may be associated with reduced ovarian reserve

Erica T Wang et al. Fertil Steril. 2014 Dec.

Abstract

Objective: To determine whether BRCA carriers have a decreased ovarian reserve compared with women without BRCA mutations, because BRCA mutations may lead to accelerated oocyte apoptosis due to accumulation of damaged DNA.

Design: Cross-sectional study.

Setting: Academic tertiary care center.

Patient(s): A total of 143 women, aged 18-45 years, who underwent clinical genetic testing for BRCA deleterious mutations because of a family history of cancer, were included. The cohort was classified into three groups: BRCA1 carriers, BRCA2 carriers, and women without BRCA mutations (controls). None had a personal history of breast or ovarian cancer.

Intervention(s): None.

Main outcome measure(s): The main outcome was serum antimüllerian hormone (AMH) level. Linear and logistic regression models adjusting for age and body mass index (BMI) were performed to determine the association between BRCA mutations and AMH.

Result(s): BRCA1 mutation carriers had a significant decrease in AMH levels compared with controls after adjusting for age and BMI (0.53 ng/mL [95% confidence interval (CI) 0.33-0.77 ng/mL] vs. 1.05 ng/mL [95% CI 0.76-1.40 ng/mL]). Logistic regression confirmed that BRCA1 carriers had a fourfold greater odds of having AMH <1 ng/mL compared with controls (odds ratio 4.22, 95% CI 1.48-12.0). There was no difference in AMH levels between BRCA2 carriers and controls.

Conclusion(s): BRCA1 carriers have lower age- and BMI-adjusted serum AMH levels compared with women without BRCA mutations. Our results contribute to the current body of literature regarding BRCA carriers and their reproductive outcomes. Larger prospective studies with clinical outcomes such as infertility and age at menopause in this population are needed to further substantiate our findings.

Keywords: Antimüllerian hormone; BRCA mutations; ovarian reserve.

PubMed Disclaimer

References

    1. King MC, Marks JH, Mandell JB New York Breast Cancer Study G. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science. 2003 Oct 24;302(5645):643–6. - PubMed
    1. Cass I, Baldwin RL, Varkey T, Moslehi R, Narod SA, Karlan BY. Improved survival in women with BRCA-associated ovarian carcinoma. Cancer. 2003 May 1;97(9):2187–95. - PubMed
    1. Acog. ACOG Practice Bulletin No. 89. Elective and risk-reducing salpingo-oophorectomy. Obstetrics and gynecology. 2008 Jan;111(1):231–41. - PubMed
    1. Practice Committee of the American Society for Reproductive M. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertility and sterility. 2012 Dec;98(6):1407–15. - PubMed
    1. Scully R, Livingston DM. In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature. 2000 Nov 23;408(6811):429–32. - PMC - PubMed

Publication types